drugset / Trial / NCT01734447
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to assess the safety of long-term growth hormone treatment in growth-retarded children with intrauterine growth retardation (IUGR) enrolled in trial GHRETARD/F/1/F.
Timeline
- Start
- 2000-04-30
- Primary completion
- 2003-04-30
- Completion
- 2003-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 1.2 iu/kg | — |
| Subject | Somatropin | Protein / enzyme biologic | 2.4 iu/kg | — |